Antiviral Natural Product Combination, in Particular for the Treatment of SARS-CoV-2 Infections
Simple SummaryContent extracted from patent full text and abstract with AI.
The invention outlines a safe and simple antiviral composition made from natural substances aimed particularly at combating coronaviruses such as SARS-CoV-2. This formulation combines a bioflavonoid, a salicylate, vitamin D, and optionally ascorbate (vitamin C), calcium, and magnesium to boost antiviral effects.
Use CasesContent extracted from patent full text and abstract with AI.
- Treatment or supportive therapy for SARS-CoV-2 (COVID-19) infections
- Treatment or prevention of illnesses caused by other coronaviruses
- General immune system strengthening for viral infection prevention
- Development of over-the-counter antiviral supplements
- Adjunctive use alongside conventional antiviral medications in clinical settings
BenefitsContent extracted from patent full text and abstract with AI.
- Composed of well-known, safe natural ingredients with established safety profiles
- May reduce the severity or duration of coronavirus infections
- Easily produced and administered as a supplement or supportive therapy
- Likely to have fewer side effects compared to synthetic pharmaceuticals
- Can be used as a preventive measure during viral outbreaks
Technical Classifications (CPCs)
Main Classifications
Health, Food & Consumer Tech
Sub Classifications
Medical & Vet Science
CPC Codes
Inventors & Applicants
Inventors
Applicants
Technische Univ Bergakademie Freiberg Koerperschaft des Oeffentlichen Rechts
Patent Abstract
Die Erfindung betrifft ein einfaches unbedenkliches Mittel mit antiviraler Wirkung gegen Coronaviren speziell SARS-CoV-2. Dazu wird ein Bioflavonoid in Kombination mit einem Salicylat und Vitamin D und ggf. einem Ascorbat, Calcium und Magnesium eingesetzt.
Key Information
Publication No.
DE102021115792A1
Family ID
80000669
Publication Date
2022-02-17
Application No.
DE102021115792A
Application Date
2021-06-18
Priority Date
2021-06-18
Granted
No
Possible Cooperation
For further information please contact the transfer office.